The monoamine catabolic enzyme arylalkylamine N-acetyltransferase 1 (AANAT1) is expressed by astrocytes and subsets of serotonergic, glutamatergic, GABAergic and cholinergic neurons in the adult brain of Drosophila.
regions associated with sleep regulation (Fig. S1) . AANAT1 expression was largely absent from the neuropils of the mushroom body and fan-shaped body (FSB), though there were scattered AANAT1-positive astrocytes nearby. AANAT1 expression in the neuropil of the ellipsoid body (EB) came almost exclusively from neurons (Fig. S1) . Elsewhere, AANAT1 expression came primarily from the infiltrative processes of astrocytes, as in the neuropil regions of the antennal lobe and subesophageal ganglion. Overall, it appeared that astrocytes contributed far more to AANAT1 labeling of brain neuropil than did neurons.
The monoamines serotonin, dopamine, and octopamine (the insect homolog of norepinephrine) are known to act in the fly brain to regulate the quantity and timing of sleep [2] . Pharmacological, genetic, and thermogenetic approaches have converged to demonstrate that serotonin signaling in the fly brain increases sleep, whereas dopamine or octopamine signaling promote waking [2, 12, [18] [19] [20] [21] [22] . Previous studies have suggested AANAT1 expression in dopaminergic neurons [23, 24] , but this has not been tested directly. With IHC, we examined AANAT1 co-labeling of serotonergic, dopaminergic and octopaminergic neurons using a mCD8-GFP reporter driven by either Trh-Gal4 [25] , TH-Gal4 [26] , or Tdc2-Gal4 [27] , respectively. AANAT1 was expressed in an average of 14.5 ± 4.8 of 60 ± 3.4 (25%) of serotonergic cells labeled with Trh>mCD8-GFP ( Fig. 1H , I-I'',N). AANAT1 + serotonergic neurons belonged to a medial subeosophageal ganglion cluster. However, AANAT1 did not co-label cells expressing TH>mCD8-GFP or Tdc2>mCD8-GFP ( Fig. 1J, K 6 To identify the other types of neurons expressing AANAT1, we used a mCD8-GFP reporter driven by either MiMIC-vGlut, Gad1-Gal4, or Cha-Gal4 and found AANAT1 in subpopulations of neurons that release glutamate, gamma-aminobutyric acid (GABA), or acetylcholine, respectively ( Fig. S1 ). Monoamines are mainly synthesized in the neurons that release them, and it is generally understood that their re-uptake into these same neurons occurs via specific transport proteins to prevent their accumulation at synapses [29] .
Absence of AANAT1 from dopaminergic or octopaminergic neurons showed that cells that produce and release monoamines do not necessarily contribute to their catabolism via AANAT1. However, the presence of AANAT1 in subsets of glutamatergic, GABAergic and cholinergic neurons suggests that, along with astrocytes, these non-monoaminergic neurons could contribute to regulation of monoamine bioavailability in the brain.
The AANAT1 gene produces two isoforms, the shorter of which (FlyBase AANAT1-PA, 240aa in length), previously known as aaNAT1b, is more predominant [30] .
This shorter isoform was observed to be lost in AANAT1 lo mutants [31] . AANAT1 lo is a spontaneous mutation that arose from insertion of a transposable element into the AANAT1 gene, and extracts of these flies have reduced AANAT1 activity [31, 32] . Using our new AANAT1 antiserum to perform Western blotting of brain extracts, we observed only the short isoform in controls. In AANAT1 lo homozygotes and hemizygotes (AANAT1 lo /In(2LR)Px [4] ), AANAT1 protein levels were reduced to 13% and 8% of iso31 controls, respectively ( Fig. 2A,B) . This was confirmed with IHC in the brains of AANAT1 lo flies ( Fig. 2C-E) , where we noted residual AANAT1 expression in some Elav + neurons, but complete loss of AANAT1 from astrocytes ( Fig. 2F-F ', G-G'). 7 In vitro studies have shown that serotonin and dopamine are substrates for AANAT1 with similar affinities [17] . Whether the levels of these and/or other monoamines are regulated by AANAT1 in vivo remains to be determined. We used HPLC-MS to measure levels of serotonin, dopamine, and octopamine in the brains of AANAT1 lo flies and controls (iso31) (Fig. 2H) . Under baseline sleep-cycle conditions, where brain tissues were collected in a 3-hour window after lights-ON (ZT0), serotonin and dopamine levels in AANAT1 lo flies were similar to controls ( Fig. 2I) . Octopamine was undetectable in controls, and found at low levels in brains of AANAT1 lo flies ( Fig. S2) . However, if this window was preceded by 12 hours (ZT12-ZT24) of sleep deprivation, AANAT1 lo brains had a robust increase in the levels of serotonin and dopamine compared to controls ( Fig. 2I ), but this had no effect on octopamine levels ( Fig. S2) . Importantly, in control animals the sleep deprivation protocol itself did not appear to affect the levels of measured monoamines, or of AANAT1 itself ( Fig. 2J, K) . Further, we did not observe changes in the levels of another monoamine catabolic enzyme known to be expressed in astrocytes (Ebony) in either AANAT1 lo flies, or in flies subjected to sleep deprivation ( Fig. S2) . We conclude that catabolism of serotonin and dopamine in the brains of flies lacking AANAT1 is severely compromised upon sleep deprivation, leading to inappropriate accumulation of these monoamines.
AANAT1 lo increases homeostatic sleep following deprivation [16] , suggesting AANAT1 could be key to how the brain limits the response to sleep deprivation. AANAT1 lo is also interesting because these flies have normal activity, and intact daily patterns of sleep [16] , allowing genetic dissection of homeostatic sleep control independent of the regulation of baseline sleep. We wondered whether the increased rebound sleep seen in AANAT1 lo 8 animals could be explained by loss of AANAT1 function from neurons or astrocytes. To test this, we selectively knocked down AANAT1 in distinct cell types with RNAi, and measured both baseline and homeostatic sleep with the Drosophila Activity Monitoring System (DAMS). To evaluate the contribution of neuronal AANAT1 in sleep, we tested nSyb-Gal4>UAS-AANAT1-RNAi flies and found that they displayed normal patterns of baseline sleep ( Fig. 3A-H) , as reported for the AANAT1 lo allele [16] . However, knockdown of AANAT1 in neurons increased the amount of nighttime sleep compared to controls ( Fig.   3B , F). In addition, AANAT1 knockdown in neurons led to sleep bouts during the night that were increased in duration and decreased in number, suggesting improved sleep consolidation at night ( Fig. 3C-D ;G-H). This was observed for two independent RNAi lines that target the AANAT1 transcript at distinct sites, though the effect was stronger for one (AANAT-RNAi 2, JF02142) than the other (AANAT-RNAi 1, HMS01617). We then assessed whether AANAT1 knockdown in neurons (nSyb>AANAT1-RNAi) would impact sleep rebound after sleep deprivation, as was observed in AANAT1 lo flies. For this, flies were subjected to overnight mechanical sleep deprivation and we found, somewhat surprisingly, that these flies do not display an enhanced rebound sleep the next day ( Fig. 
3I-L).
Flies lacking AANAT1 in neurons were not totally deprived of sleep by the mechanical stimulation, but as this was also the case in one of the controls, it is not indicative of a phenotype of AANAT1 loss.
Next, we used Alrm-Gal4 to selectively deplete AANAT1 expression from astrocytes with RNAi (Alrm>AANAT1-RNAi). This had no effect on the numbers of astrocytes present in the brain (Fig. 4A) , and flies showed normal baseline patterns and amounts of daytime and nighttime sleep compared to controls carrying either GAL4 or 9 UAS transgenes alone ( Fig. 4B-E) , consistent with reported normal circadian sleep-cycle and motor activity of AANAT1 lo [16] . However, upon overnight mechanical sleep deprivation, these flies had increased rebound sleep the next day ( Fig. 4F-I Fig. 4J ). Incomplete rescue might be explained by our observation that AANAT1-myc was not detectable in many brain astrocytes in these animals ( Fig. 4K) . Taken together, our results demonstrate that AANAT1 acts in astrocytes, but not in neurons, to restrict daytime rebound sleep in response to overnight sleep deprivation. Along with our finding that AANAT1 limits accumulation of serotonin and dopamine upon sleep deprivation, these data suggest that Drosophila astrocytes are specifically engaged to handle particular demands on monoamine metabolism imposed by sleep deprivation overnight.
With IHC we examined AANAT1 under baseline sleep-cycle conditions at 3 hr intervals during the dark period ZT12-ZT24. Interestingly, we found that AANAT1 expression in astrocytes peaked at ZT15, declined markedly to undetectable levels by ZT21 ( Fig. 4L) , and was re-established at lights-ON (ZT24). From this we infer that the loss of AANAT1 might have more profound effects during ZT12-15 of sleep deprivation, or during daytime afterward, though further temporal refinement of astrocytic AANAT1 function is required. AANAT1 is expressed in astrocytes that reside throughout the brain, and so it remains unclear whether it modulates sleep homeostasis by acting within a particular region of the brain, or more broadly. Interestingly, the neuropils of key sleep centers (EB and FSB; Fig. S1 ) had no AANAT1 staining from infiltrative astrocytes, 10 raising the likelihood it acts elsewhere. Finally, it remains to be established whether the effect of AANAT1 on sleep homeostasis is due to serotonin, dopamine, or both. In Drosophila, serotonergic signaling in the brain promotes sleep, while dopaminergic signaling promotes waking. Levels of both serotonin and dopamine are upregulated in AANAT1 lo mutants upon sleep deprivation, where increased sleep prevails. It stands to reason that AANAT1 could act in astrocytes to limit the deprivation-dependent accumulation of sleep-promoting serotonin. It is also possible that dopamine accumulation plays a role, since thermogenetic activation of wake-promoting dopaminergic neurons at night promotes compensatory sleep the next day. This suggests these particular neurons are upstream of circuits that produce homeostatic responses to extended wakefulness [13, 33] , and astrocytic AANAT1 could somehow restrict dopaminergic signaling from these neurons overnight.
Our findings illustrate a newly-discovered role for astrocytes in the control of monoamine bioavailability and homeostatic sleep drive. Drosophila astrocytes also express the enzyme Ebony, which couples dopamine to N-β-alanine [34] , and a receptor for octopamine and tyramine [35] , reinforcing how they are well-equipped to metabolize monoamines, and to monitor and respond to monoaminergic neuronal activity. Neither gene expression studies nor RNA sequencing databases provide evidence for monoaminesynthesizing enzymes in Drosophila astrocytes, so it appears likely that monoamines inactivated by AANAT1 in astrocytes are brought into these cells by an unidentified transporter. Astrocytes are particularly well-suited for regulating sleep in this way because they have ramified processes that infiltrate neuropil regions to lie in close proximity to synapses. 11 AANAT1 also functions in neurons to regulate baseline sleep, which highlights the idea that cellular context has profound impact on AANAT1 function in sleep regulation. In light of this, we note that loss of the related enzyme aanat2 in zebrafish larvae decreases baseline sleep [36] , which could be attributed to a loss of melatonin since the AANAT1 product N-acetylserotonin is an intermediate in the synthesis of melatonin in vertebrates [31] . Clearly, the appropriate balance and cellular context of AANAT activity is critical for the regulation of sleep, and we show here in Drosophila that astrocytes are an important contributor to this balance. Interestingly, astrocytes in rodents express the monoamine transporters and receptors for dopamine and serotonin [37] [38] [39] [40] [41] [42] , raising the possibility that astrocytes in mammals might also participate in mechanisms of sleep regulation involving monoaminergic neural signaling.
Methods

Fly stocks
Drosophila melanogaster stocks were obtained from the Bloomington Drosophila Stock 
Generation of AANAT1 antibody
A KLH-coupled peptide RRPSPDDVPEKAADSC (amino acids (aa) 94-109 of isoform AANAT1-PA (FlyBase), or 129-144 of isoform AANAT1-PB) was synthesized and 13 injected into rabbits according to guidelines of the Canadian Council for Animal Care (MEDIMABS, Montreal, QC).
Immunohistochemistry and imaging
Adult fly brains were dissected in cold phosphate-buffered saline (pH 7.4) and fixed in 4% For MCFO labeling, brains were dissected in ice-cold PBS, fixed with 4% paraformaldehyde/PBS for 1 h at room temperature followed by three successive washes in 0.5% PBTx for 20 min each. Simultaneous incubation (48 h at 4 °C) with rat anti-FLAG
(1:100; Novus Biologicals NBP1-06712,A-4) and rabbit anti-AANAT1 was followed by 14 another 48 h at 4 °C with goat anti-rabbit (1:1000; Alexa Fluor 488, Thermo Fisher Scientific, #A11008), goat anti-rat (1:1000; Alexa Fluor 568, #A11077) and V5tag:AlexaFluor-647 (1:200; Bio-Rad MCA1360A647).
To quantify cells immuno-labelled for GFP and AANAT1, cells were manually counted from image stacks of the central brain (excluding optic lobes).
Western blotting
Lysates for western blots were prepared from dissected adult brains in 50μl Laemmli buffer as reported in [45] . 10 brains were used per lysate and incubated at 90⁰C for 5 min. 15μl
of each sample was loaded per well, run on 15% SDS-PAGE gels, blotted to nitrocellulose membrane, and probed with Rabbit anti-AANAT1 (1:2500) or anti-Ebony (1:3000; Sean Carroll, University of Wisconsin-Madison), and mouse anti-actin (1:3000; Sigma #A4700). HRP-conjugated secondary antibodies anti-rabbit (1:3000; Bio-Rad) and antimouse (1:3000; Promega #W4021) were used for detection with chemiluminescence (HyGLO Chemiluminescent HRP Antibody Detection Reagent, Denville Scientific). Mean signal intensity for AANAT1 or Ebony was quantified using Fiji and normalized to actin.
We used three separate lysates for each genotype to analyze western blots. For sleep experiments, female brains were used for lysate preparation.
High Performance Liquid Chromatography -Mass Spectrometry (HPLC-MS)
To prepare samples for HPLC-MS, the brains of twenty female flies (1-2 weeks old) for each genotype were dissected into ice-cold PBS between ZT0.5-3.5. We dissected brain tissue to avoid cuticle contamination because serotonin and dopamine are intermediates in the sclerotization of Drosophila cuticle. Dissected brains were centrifuged, the PBS was 15 removed, and samples were quickly homogenized with a motorized pestle into an aqueous solution of formic acid (0.1%). After centrifugation, the supernatant was collected and stored at -80ºC. Preliminary analytical conditions were developed using reference standards in a solution containing either serotonin, dopamine, or octopamine. With LC-MS/MS (Thermo-Scientific Quantiva Triple Quadrupole Mass Spectrometer (QQQ)), the absolute values for each analyte were measured in picograms (pg) per brain, through the addition of deuterated reference standards to sample extracts.
Monitoring and measurement of sleep in Drosophila
Prior to experimentation, flies were kept on standard food in constant conditions (a 12-hour light/dark cycle, and 25°C). At least 5 days after eclosion, mated adult females were loaded into glass tubes with 5% sucrose/2% agar food for behavioral recordings. The Drosophila Activity Monitoring (DAM) system (Trikinetics, Waltham, MA) was used to quantify infrared beam breaks representing locomotor activity. Files were processed with PySolo [46] in 1-minute bins, with sleep defined as 5 consecutive minutes without activity, as done previously [47] . In sleep deprivation experiments, flies were placed in DAM monitors on a vortexer that was mechanically shaken a random 2 of every 20 seconds over the course of the 12 hours of the dark period (ZT12-24). Rebound sleep was determined, per fly, as the difference between sleep amount in the period following deprivation and sleep amount in the same time period on the preceding baseline day in unperturbed conditions.
Time-course of AANAT1 expression in astrocytes
AANAT1 levels in astrocytes were quantified at 3 hr intervals between ZT12-24 with IHC,
where AANAT1 fluorescence intensity in astrocyte cell bodies was measured and normalized to nuRFP intensity from 2 copies of a UAS-nuRFP transgene reporter driven 16 by Alrm-Gal4. At each time point, 10 astrocytes in the antennal lobe region were measured from each of three brains. 
Figure Legends
